Share
Market Research Report

MICE MODEL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Model TypeGenetically Engineered Mice (GEM) (Knockout Mice, Knock-in Mice, and Conditional Mutant Mice) · Inbred Mice · Outbred Mice · Hybrid/Congenic Mice · and Spontaneous Mutant Mice
  • By ServiceBreeding Services · Cryopreservation · Rederivation · and Resequencing Services · Genetic Testing and Characterization Services · Model In-vivo and In-vitro Testing Services · and Custom Model Development Services
  • By TechnologyCRISPR/Cas9 · Embryonic Stem Cell (ESC) Technology · Nuclear Transfer Technology · Microinjection Technology · and Others (e.g., TALENs, ZFNs)
  • By ApplicationOncology Research · Immunology and Inflammation Studies · Diabetes Research · Cardiovascular Research · Neurological Disease Research · Rare Disease Research · Toxicology and Safety Assessment · and Others (e.g., Metabolic Disorders, Infectious Diseases)
  • By End UserPharmaceutical and Biotechnology Companies · Academic and Research Institutions · Contract Research Organizations (CROs) · and Government and Nonprofit Organizations
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In10 Mar 2026
  • Report CodeCMI8435
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Model Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Genetically Engineered Mice (GEM)
      • Knockout Mice
      • Knock-in Mice
      • Conditional Mutant Mice
    • Inbred Mice
    • Outbred Mice
    • Hybrid/Congenic Mice
    • Spontaneous Mutant Mice
  • Service Insights (Revenue, USD Bn, 2021 - 2033)

    • Breeding Services
    • Cryopreservation, Rederivation, and Resequencing Services
    • Genetic Testing and Characterization Services
    • Model In-vivo and In-vitro Testing Services
    • Custom Model Development Services
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)

    • CRISPR/Cas9
    • Embryonic Stem Cell (ESC) Technology
    • Nuclear Transfer Technology
    • Microinjection Technology
    • Others (e.g., TALENs, ZFNs)
  • Application Insights (Revenue, USD Bn, 2021 - 2033)

    • Oncology Research
    • Immunology and Inflammation Studies
    • Diabetes Research
    • Cardiovascular Research
    • Neurological Disease Research
    • Rare Disease Research
    • Toxicology and Safety Assessment
    • Others (e.g., Metabolic Disorders, Infectious Diseases)
  • End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutions
    • Contract Research Organizations (CROs)
    • Government and Nonprofit Organizations
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa